DSRU Scientific Publications
Use our keyword search facility to match our publications with your area of interest.
253 publications found, showing 41 to 60
-
Bill Inman: drug safety physician and pharmacoepidemiologist
Shakir SA,
Drug Saf. January 2006 -
Comparison of the risk of drowsiness and sedation between levocetirizine and desloratadine: a prescription-event monitoring study in England
Layton D, Wilton L, Boshier A, Cornelius V, Harris S, Shakir SA,
Drug Saf. January 2006 -
Prescription-event monitoring study on 13,164 patients prescribed risedronate in primary care in England
Barrera BA, Wilton L, Harris S, Shakir SA,
Osteoporos Int. December 2005 -
Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia
Layton D, Harris S, Wilton LV, Shakir SA,
J Psychopharmacol. September 2005 -
Deep vein thrombosis and pulmonary embolism reported in the Prescription Event Monitoring Study of Yasmin
Pearce HM, Layton D, Wilton LV, Shakir SA,
Br J Clin Pharmacol. July 2005 -
The negative effect of red tape on research
Boshier A, Shakir SA, Telfer P, Behr E, Pakrashi T, Camm AJ,
Pharmacoepidemiol Drug Saf. June 2005 -
Safety profile of raloxifene as used in general practice in England: results of a prescription-event monitoring study
Layton D, Clarke A, Wilton LV, Shakir SA,
Osteoporos Int. May 2005 -
Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study
McKenna K, Koren G, Tetelbaum M, Wilton L, Shakir S, av-Citrin O, Levinson A, Zipursky RB, Einarson A,
J Clin Psychiatry. April 2005 -
The safety and effectiveness of newer antiepileptics: A comparative postmarketing cohort study
Acharya NV, Pickering RM, Wilton LW, Shakir SAW,
J Clin Pharmacol. April 2005 -
Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study
Chun-Fai-Chan B, Koren G, Fayez I, Kalra S, Voyer-Lavigne S, Boshier A, Shakir S, Einarson A,
Am J Obstet Gynecol. March 2005 -
Hospital admissions for 'drug-induced' disorders in England: a study using the Hospital Episodes Statistics (HES) database
Waller P, Shaw M, Ho D, Shakir S, Ebrahim S,
Br J Clin Pharmacol. February 2005 -
Observational cohort study to monitor the use and safety of carvedilol in the treatment of heart failure in clinical practice in England--1st interim report
Acharya NV, Wilton LV, Shakir SA,
Int J Clin Pharmacol Ther. January 2005 -
A comparison of reported gastrointestinal and thromboembolic events between rofecoxib and celecoxib using observational data
Kasliwal R, Layton D, Harris S, Wilton L, Shakir SA,
Drug Saf. January 2005 -
Relative risk of vaginal candidiasis after use of antibiotics compared with antidepressants in women (multiple letters)
Elliott R, Wilton LV, Kollarova M, Heeley E, Shakir S,
Drug Saf. January 2005 -
Safety profile of celecoxib as used in general practice in England: results of a prescription-event monitoring study
Layton D, Wilton LV, Shakir SA,
Eur J Clin Pharmacol. September 2004 -
Re: Layton et al. Comparison of the incidence rates of selected gastrointestinal events reported for patients prescribed rofecoxib and meloxicam in general practice in England using prescription-event monitoring data (multiple letters) [12]
Degner F, Lesaffre E, Zeidler H, Layton D, Harris S, Shakir S,
Rheumatology. May 2004 -
Identification and evaluation of a possible signal of exacerbation of colitis during rofecoxib treatment, using Prescription-Event Monitoring data
Layton D, Heeley E, Shakir SA,
J Clin Pharm Ther. April 2004 -
Evaluation of the safety of sildenafil for male erectile dysfunction: experience gained in general practice use in England in 1999
Boshier A, Wilton LV, Shakir SA,
BJU Int. April 2004 -
Do some inhibitors of COX-2 increase the risk of thromboembolic events?: Linking pharmacology with pharmacoepidemiology
Clark DW, Layton D, Shakir SA,
Drug Saf. January 2004 -
Causality and Correlation in Pharmacovigilance
Shakir SAW,
Stephens' Detection of New Adverse Drug Reactions. January 2004